3 115

Cited 16 times in

Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program

Authors
 Sevil Bavbek  ;  Alfonsus J.M. van den Eertwegh  ;  Viktor Grünwald  ;  Oezlem Anak  ;  Ashok Panneerselvam  ;  Dennis Kim  ;  Yen-chuan Ou  ;  Amit Bahl  ;  Sergio Bracarda  ;  Sun Young Rha  ;  Pierre Karakiewicz 
Citation
 Urology, Vol.81(1) : 143-149, 2013 
Journal Title
 Urology 
ISSN
 0090-4295 
Issue Date
2013
Abstract
OBJECTIVE: To retrospectively analyze the effects of treatment duration on outcomes of everolimus treatment of patients in the RAD001 Expanded-Access Clinical Trial in RCC (REACT) program. METHODS: Patients with metastatic renal cell carcinoma refractory to vascular endothelial growth factor receptor-tyrosine kinase inhibitor received everolimus (10 mg once daily), with dosing interruption or modifications allowed for toxicity. All serious and grade 3/4 adverse events and grade 1/2 adverse events leading to a change in drug administration were reported. Tumor response was evaluated using Response Evaluation Criteria In Solid Tumors. RESULTS: The study stratified 1367 evaluable patients into treatment duration groups of <3 months, ≥3 and <6 months, ≥6 months and <1 year, and ≥1 year. Pneumonia, noninfectious pneumonitis, and hyperglycemia occurred more frequently in patients receiving everolimus for ≥1 year but did not result in treatment discontinuations. First occurrence of adverse events presented early in the treatment course for most patients. Treatment duration of ≥6 months was associated with improved disease control rates. CONCLUSION: Everolimus is well tolerated in patients with metastatic renal cell carcinoma for treatment durations≥1 year and not associated with cumulative toxicity.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/86583
DOI
10.1016/j.urology.2012.09.019
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실)
Yonsei Authors
라선영(Rha, Sun Young)
사서에게 알리기
  feedback
Full Text
http://www.sciencedirect.com/science/article/pii/S0090429512011107
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse